Japan approves Alzheimer treatment Leqembi by Eisai and Biogen

(Reuters) – Japan’s Eisai (4523.T) said on Monday the country’s health ministry had approved its Alzheimer treatment Leqembi, co-developed with U.S.-based Biogen (BIIB.O). The development comes after a health ministry panel recommended the drug’s approval in August, followed by standard approval from the U.S. Food and Drug Administration (FDA) in July. The drug is the […]